Ranbaxy gets $4-M milestone payment

By siliconindia staff writer   |   Wednesday, 23 June 2004, 07:00 Hrs
Printer Print Email Email
MUMBAI: Ranbaxy Laboratories Ltd said on Wednesday it has received a milestone payment of $4 million from Schwarz Pharma AG for further development of its benign prostate hyperplasia molecule licensed to the German firm.
Ranbaxy had licensed the molecule to Schwarz in June 2002.

Schwarz Pharma completed Phase I clinical trials in Europe and the molecule is now moving into Phase II trials in Europe and South Africa, Ranbaxy said in a statement.



SPOTLIGHT
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..